Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0A9M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,907
Award facts
- Contract value 100% obligated
- $19,906.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,906.69 by the Defense Logistics Agency on January 30, 2026, for the supply of Dupixent 300 mg/2 mL pens. The contract, with an ultimate completion date of February 2, 2026, carries firm fixed pricing and no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the parent indefinite delivery contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 2031. The Defense Logistics Agency, a component of the Department of Defense, procures pharmaceuticals and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This award demonstrates AmerisourceBergen's ongoing role as a critical vendor in the federal pharmaceutical supply chain, delivering specialty medications and other healthcare commodities essential to military and defense operations.
Quick answers
Who was awarded contract SPE2DR26F0A9M?
SPE2DR26F0A9M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F0A9M worth?
The government has obligated $19,907 on SPE2DR26F0A9M.
Is contract SPE2DR26F0A9M an order under another contract?
Yes. SPE2DR26F0A9M is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A9M competed?
The extent of competition for SPE2DR26F0A9M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award